#SUVENPHAR #BANKNIFTY #NIFTY #TRADING #COVID19 #SUVEN #PHARMA#SUVENPHAR #SUVEN
Suven Pharmaceuticals Ltd.
CMP: 676.90
Target: 708 / 750
SL: 644
PHARMA
Pharma looks fugly on a relative basisBreaking down through support, this is what kept me out of trading PFE to the long-side even though it looked bullish. With the elections coming up and democrats leading the polls, I'd stay away from pharma and insurers. Lean towards medical devices if you need healthcare exposure.
Sun pharmaHello!! Sun pharma is a great stock now. this stock is in an indecisive position wait for the confirmation as if it breaks the support of 522 then lower levels can be seen but if it sustains over it then around 553 can be seen. #MY_VIEW #LEARNER
BIOSEARCH: Potential H&S despite good fundamentalsOn July 10, after issuing a warning that the firm would expect higher than usual profits, BIOS jumped >20% that friday. Then, once its quarterly earnings were released, it was clear the company had not tricked us: + 25.8% REVENUES OF 14.3 MILLION IN THE FIRST SEMESTER, +44.2% to 5.5 million euros in Plant extracts business line, probiotics business registered a growth of 47.4%, standing at 3.2 million euros, driven mainly by the Women’s Health segment. Net profit was up +501,7% in the first semester of 2020. EBITDA of €1,96 million (+92,8% Semester over Semester).
However, technical analysis suggests to short the company until 1.04 or even 0.95 level (and some other analysts from FX Street say 0.87). As it is usual in summer, the company is experiencing low volume levels so if volume starts increasing, BIOS' share price may go up easily as Reig Jofre or ROVI did. So, long-term trend is bullish up until 2018 maximums of 1.95-2€. August is bearish.
relatively high PER: (57*1.13)/1.04 = 62
Not higher than RJFE's PER = 77
ROVI's PER = 95
And lower than:
FAES FARMA PER = 21.53 (very undervalued in my opinion)
PHARMA MAR PER = 14 (unstable company, needs more history to determine its viability. it could certainly be a good investment due to its low PER, but remember first semester 2019 it experienced losses instead of profits)
These PERs here were calculated based on net profit from first semester 2020 only.
Is this Hikma's cue for a break out?Will Hikma break out after a 5 year H&S pattern,
now that it's making progress in the Covid-19 vaccine business?
AB=CD Pattern Replacement to Catch the TrendAURO Pharma is on marathon but a sprint marathon exhausts the athlete and the same happens to the stocks. AB=CD pattern would make the point D- a point of in flexion and fall all the way to POC level marked, from where again a buying opportunity can be tapped by the incumbent buyers and from the initiative buyer looking for a discounted entry .
Torrent pharmaHello !! torrent pharma is quite at all-time highs it just gave a very big up move on a day before last market day so it's more prone to be rangebound or a bit of retracement, if it doesn't break upper resistance and sustains a rangebound session can be seen but if it breaks the final resistance then it will be on the all-time highs so the target is difficult to give. #my_view #learner
CiplaHello!! Cipla is a famous company for pharma in India but I don't like much of pharma stocks, still this stock looks bullish for a short term and maybe will retrace a bit or rangebound because it has given a big move on last market day..... I think 745 tgt can be seen till 6th august 2020. #my_view #learner
Pennystock Wedgie. (ZOM)I will be trying to add 1% to this position around 13 cents p/share for a test on the recent bottom.
If breaks, will drop to the bottom of the wedge as we try to create the wave 5 of retracement.
Will look to add 0.5% if it does touch bottom of wedge.
This will be a longterm play with anticipation to breakout of the wedge for a impulse.
TORNTPHARMA SWING AND BREAKOUT TRADING IDEATORNTPHARMA SWING AND BREAKOUT TRADING IDEA
FRIENDS IF YOU LIKE THEN PLEASE LIKE AND SHARE.
Santen Analysis SNPHYFormations drawn
Rising Wedge
Scythe
I expect a breakdown of this weird wedge that has formed between a major trendline and a line of strong bounce areas
A very good potential pharma company to invest for good returns.One can trade in this script with immediate target of 570 followed by 610 and higher before stock split, keep stop loss at 500. Good luck and have a great profitable day.
For long term investors keep it in your portfolio and hold for multi fold returns.
for more you can visit my site 5nancial.blogspot.com
BUY GUFIC BIO FOR INVESTMENTGUFIC BIO PERFECT ROUNDING BOTTOM PATTERN ON CHARTS, PERFECT PICK FOR MEDIUM TERM INVESTMENTS. CMP -78
BULLISH MOVES ON MONDAY [AUDNZD]The price failed to break our support zone so many times, it seems like that is an area where buyers are stepping in and push the price higher
any other ideas?? please comment your idea
8p/9.15p 1st targets - low downside / undervaluedPlacing was at 6.15p
Jupiter fund seller out - TR1 to confirm
BoD own 11% of the company
Acquisition of hVIVO back in December 2019
New presentation online
at £28.6m mcap we are undervalued
I have 8p as 1st target but we could breakout eventually & head to 9.15p then pullback to 8p & continue the bull trend after.
Will re-evaluate once we hit 8p.
Company looks very impressive so not afraid to add further on weakness.
